WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Harlan S. RobinsChief Scientific Officer2025-12-0410,000$16.61
$166.10kSell
Harlan S. RobinsChief Scientific Officer2025-12-0327,212$18.61
$506.42kSell
Chad M. RobinsCEO and Chairman2025-12-01124,998$18.94
$2.37MSell
Kyle PiskelChief Financial Officer2025-11-2894,384$12.14
$1.15MBuy
Kyle PiskelChief Financial Officer2025-11-28162,820$19.50
$3.17MSell
Kyle PiskelChief Financial Officer2025-11-2811,980$6.55
$78.47kBuy
Kyle PiskelChief Financial Officer2025-11-283,750$7.80
$29.25kBuy
Chad M. RobinsCEO and Chairman2025-11-2635,736$19.68
$703.28kSell
Sharon BenzenoChief Commercial Ofc Imm Med2025-11-2134,375$7.27
$249.91kBuy
Sharon BenzenoChief Commercial Ofc Imm Med2025-11-21119,809$12.14
$1.45MBuy

1 of 6

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC20.30%30,993,708$457.16MInsider
Viking Global Investors LP19.65%29,993,708$442.41MInsider
Viking Global Investors LP19.65%29,993,708$442.41MInstitution
Blackrock Inc8.75%13,357,977$197.03MInstitution
David E. Goel8.06%12,310,594$181.58MInsider
Vanguard Group Inc7.39%11,275,169$166.31MInstitution
Chad M. Robins4.03%6,146,741$90.66MInsider
Ameriprise Financial Inc3.91%5,971,706$88.08MInstitution
Amova Asset Management Americas Inc2.39%3,650,646$53.85MInstitution
Sumitomo Mitsui Trust Group Inc2.39%3,650,646$53.85MInstitution

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT62.16%37.84%Net SellingNet Selling
IBRX14.52%7.76%Net Buying
MESO0.28%0.00%
HRMY76.18%23.82%Net SellingNet Selling
SRPT84.06%15.94%Net SellingNet Selling
View Top Biotech Stocks

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 95.27% institutional shareholders, 57.99% Adaptive Biotechnologies insiders, and 0.00% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 20.30% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $457.16M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.